Associate Board of Lurie Cancer Center
![AssociateBoard2024.jpg](../images/about/AssociateBoard2024.jpg)
Mission Statement
The Associate Board of Lurie Cancer Center is a group of young professionals dedicated to advancing cancer research, education, patient care, and community benefit by funding cutting-edge research at Lurie Cancer Center.
Summer Cocktail Reception
Join us for an evening of conversation, cocktails, and hors-d'œuvres in support of novel cancer research with Lurie Cancer Center leadership, physicians, researchers, and Chicago professionals in honor of the 2024 Innovative Research Award and Inaugural Clinical Trial Award recipients. Our 3rd Annual event takes place at the Ivy Room at Tree Studios on Thursday, August 8, 2024, from 6:00 p.m. - 8:30 p.m.
Key Pillars
Focus on Innovative Research |
Learning Opportunities | Fundraising/Volunteer Opportunities |
---|---|---|
|
|
|
Past Associate Board Innovative Research Award Recipients
![]() |
2023 Innovative Research Scholar Award Recipient Kehinde U.A. Adekola, MD, MSImproving Health Disparities in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Individuals of African Descent |
![]() |
2022 Innovative Research Scholar Award Recipient Marcelo Bonini, PhDDeveloping Novel First in Kind Pharmacologic Lead Compounds for Metastatic Breast Cancer |
Watch this video to learn about the impact of Lurie Cancer Center’s Associate Board.
Contact Us
For more information or to inquire about joining the Associate Board of Lurie Cancer Center:
Nicole Langert
Director, Major Gifts
Feinberg School of Medicine
312-503-1656
nicole.langert@northwestern.edu
Lurie Cancer Center at Northwestern Memorial Hospital is once again ranked among the nation’s best on U.S. News & World Report's latest list of Best Hospital’s for Cancer.
As one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers in the country, Lurie Cancer Center is leading efforts to translate state-of-the-art research into better ways to prevent, diagnose and treat cancer.